We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+20.91%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$173M
AUM Growth
+$20M
(+13%)
Cap. Flow
-$415K
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
35.73%
Holding
114
New
14
Increased
30
Reduced
33
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STRM
Streamline Health Solutions
STRM
|
+$2.62M |
| 2 |
Digi International
DGII
|
+$2.23M |
| 3 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$1.61M |
| 4 |
RYM
RYTHM Inc
RYM
|
+$1.57M |
| 5 |
ZIXI
Zix Corporation
ZIXI
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$7.28M |
| 2 |
Vericel Corp
VCEL
|
+$4.43M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.35M |
| 4 |
SOLO
Electrameccanica Vehicles Corp. Ltd.
SOLO
|
+$2.21M |
| 5 |
Inuvo
INUV
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.04% |
| 2 | Technology | 16.06% |
| 3 | Communication Services | 5.94% |
| 4 | Industrials | 4.11% |
| 5 | Consumer Staples | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verizon
VZ
$190B
| $1.03M | 0.6% |
17,725
| – | – |
|
|
CEMI
52
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.02M | 0.59% |
+289,680
| New | +$1.61M |
|
53
Ciena
CIEN
$57.9B
| $999K | 0.58% |
18,250
| – | – |
|
|
54
Magnite
MGNI
$2.97B
| $979K | 0.57% |
23,525
-167,975
| -88% | -$7.28M |
|
55
Tactile Systems Technology
TCMD
$671M
| $969K | 0.56% |
17,792
-1,225
| -6% | -$65.6K |
|
56
Merck
MRK
$319B
| $946K | 0.55% |
12,864
| – | – |
|
|
PDCO
57
DELISTED
Patterson Companies, Inc.
PDCO
| $939K | 0.54% |
29,375
-200
| -0.7% | -$6.39K |
|
|
ASPU
58
DELISTED
ASPEN GROUP, INC.
ASPU
| $872K | 0.5% |
145,250
-2,000
| -1% | -$18K |
|
59
BioLife Solutions
BLFS
$1.63B
| $810K | 0.47% |
22,500
-14,500
| -39% | -$573K |
|
60
Gilead Sciences
GILD
$162B
| $795K | 0.46% |
12,300
+200
| +2% | +$12.9K |
|
61
International Flavors & Fragrances
IFF
$22.2B
| $762K | 0.44% |
+5,460
| New | +$706K |
|
|
IIN
62
DELISTED
IntriCon Corporation
IIN
| $760K | 0.44% |
29,650
-200
| -0.7% | -$4.42K |
|
63
LifeVantage
LFVN
$83.4M
| $744K | 0.43% |
79,613
-197
| -0.2% | -$1.84K |
|
64
Advanced Micro Devices
AMD
$796B
| $663K | 0.38% |
8,450
| – | – |
|
|
SRGA
65
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $654K | 0.38% |
+10,000
| New | +$698K |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $645K | 0.37% |
26,950
+5,950
| +28% | +$142K |
|
67
CryoPort
CYRX
$775M
| $624K | 0.36% |
12,000
| – | – |
|
68
Apple
AAPL
$4.51T
| $605K | 0.35% |
4,950
| – | – |
|
69
ePlus
PLUS
$2.43B
| $598K | 0.35% |
12,000
| – | – |
|
70
Donaldson
DCI
$11.4B
| $556K | 0.32% |
9,567
| – | – |
|
|
PRTK
71
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $536K | 0.31% |
+75,850
| New | +$546K |
|
72
ANI Pharmaceuticals
ANIP
$1.83B
| $530K | 0.31% |
+14,666
| New | +$459K |
|
73
NXP Semiconductors
NXPI
$58.3B
| $513K | 0.3% |
2,550
| – | – |
|
74
US Bancorp
USB
$100B
| $493K | 0.29% |
8,917
| – | – |
|
75
IRIDEX
IRIX
$14.7M
| $488K | 0.28% |
72,246
-19,600
| -21% | -$113K |
|
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Perkins Capital Management held 114 positions worth $173M, up 13% from $153M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Perkins Capital Management's Q1 2021 filing shows 14 new, 30 increased, 33 reduced and 8 closed positions. Its largest new stake was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M. The largest sale was Magnite, an estimated $7.28M.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 64% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q1 2021 buy was Chembio diagnostics, Inc.: 289,680 shares worth $1.02M.
- Perkins Capital Management added most to Streamline Health Solutions in Q1 2021, an estimated $2.62M increase.
- Perkins Capital Management's biggest Q1 2021 reduction was Magnite, cutting an estimated $7.28M.
- Perkins Capital Management fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $2.35M.
- Perkins Capital Management's ten largest holdings make up 36% of its $173M portfolio in Q1 2021.
- Perkins Capital Management opened 14 new positions and closed 8 in Q1 2021.
- Perkins Capital Management's portfolio value rose 13% quarter-over-quarter to $173M.
Based on Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.